Biogen (BIIB) Return on Invested Capital (2013 - 2026)

Biogen's Return on Invested Capital history runs 11 years deep, the most recent figure standing at 0.03% for Q2 2026.

• In Q2 2026, Return on Invested Capital fell 2.0% year-over-year to 0.03%; the TTM figure through Jun 2026 stood at 0.03% (down 2.0% YoY), while the FY2024 annual figure was 0.0%, changed N/A from the prior year.
• Return on Invested Capital for Q2 2026 stood at 0.03%, up from 0.05% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.02% in Q1 2022, with the low at 0.05% in Q1 2026.
• The 4-year median for Return on Invested Capital is 0.0% (2025), against an average of 0.01%.
• The sharpest annual moves came in 2025 and 2026: Return on Invested Capital grew 3 bps in 2025, then decreased 4 bps in 2026.
• Biogen's Return on Invested Capital stood at 0.02% in 2022, then sank by 118 bps to 0.0% in 2024, then sank by 88 bps to 0.01% in 2025, then slumped by 303 bps to 0.03% in 2026.
• Business Quant data shows BIIB's Return on Invested Capital at 0.03% in Q2 2026, 0.05% in Q1 2026, and 0.01% in Q4 2025.